Treating Cancer from the Outside In: The Preclinical & Early Clinical Development of PF-08052667 for Non Muscle Invasive Bladder Cancer

11:15 am - Wednesday 10th March 2027

  • Demonstrating preclinical optimisation of ADC for local bladder treatment
  • Achieving strong preclinical efficacy with limited systemic exposure
  • Spotlighting clinical development of PF 08052667

Speakers:

Senior Director, ADC Pharmacology
Pfizer